Market Cap ₹22504 Cr.
Stock P/E 116.0
P/B 11.9
Current Price ₹904
Book Value ₹ 76.2
Face Value 1
52W High ₹974
Dividend Yield 0.28%
52W Low ₹ 748.5
Relaxo Footwears Ltd is engaged in the production and trading of footwear and related merchandise. The major activity of the company is the manufacturing of footwear made normally of vulcanized or molded rubber and plastic. Its manufacturers include Hawaii, Flite, Sparx, Schoolmate, Elena, Casualz and Bahamas. Under Hawaii brand, it gives its products in diverse classes, inclusive of Hi-Fashion, which includes HF-34, HF-33 and HF-31, and Kids, inclusive of Hi Lite 03 (Kids) and HFK-04. It gives various Flite slippers which are manufactured by the usage of ethylene-vinyl acetate (EVA) era. Under Flite logo, it gives its merchandise in various classes, such as Flite EVA, together with FL-259 and FL-249, and Flite Junior, which include FI 1010 and FL 1009. Under Sparx emblem, it offers its merchandise in classes, which includes Shoe, such as SM-503 and SM-502, and Sandals, together with S S-905 and S S-904. It has production centers at Bahadurgarh (Haryana), Bhiwadi (Rajasthan) and Haridwar (Uttarakhand).
Price goes above X
Price falls below X
₹ | |
#(Fig in Cr.) | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 748 | 497 | 714 | 744 | 667 | 670 | 681 | 765 | 739 | 715 |
Other Income | 7 | 5 | 7 | 5 | 4 | 6 | 4 | 4 | 7 | 11 |
Total Income | 755 | 502 | 722 | 749 | 671 | 675 | 685 | 769 | 746 | 726 |
Total Expenditure | 585 | 431 | 598 | 622 | 581 | 610 | 609 | 647 | 631 | 624 |
Operating Profit | 170 | 71 | 124 | 127 | 90 | 65 | 77 | 122 | 115 | 102 |
Interest | 5 | 4 | 4 | 4 | 7 | 4 | 4 | 4 | 4 | 5 |
Depreciation | 27 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 35 | 37 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 138 | 40 | 92 | 94 | 54 | 30 | 41 | 85 | 76 | 60 |
Provision for Tax | 35 | 9 | 23 | 24 | 15 | 8 | 10 | 22 | 19 | 16 |
Profit After Tax | 102 | 31 | 69 | 70 | 39 | 22 | 30 | 63 | 56 | 44 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 102 | 31 | 69 | 70 | 39 | 22 | 30 | 63 | 56 | 44 |
Adjusted Earnings Per Share | 4.1 | 1.2 | 2.8 | 2.8 | 1.6 | 0.9 | 1.2 | 2.5 | 2.3 | 1.8 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1010 | 1212 | 1481 | 1712 | 1631 | 1941 | 2292 | 2410 | 2359 | 2653 | 2783 | 2900 |
Other Income | 1 | 2 | 0 | 3 | 14 | 4 | 13 | 9 | 23 | 24 | 19 | 26 |
Total Income | 1011 | 1215 | 1481 | 1715 | 1645 | 1946 | 2305 | 2420 | 2382 | 2677 | 2801 | 2926 |
Total Expenditure | 900 | 1065 | 1280 | 1472 | 1400 | 1639 | 1966 | 1999 | 1862 | 2236 | 2445 | 2511 |
Operating Profit | 111 | 149 | 201 | 243 | 245 | 307 | 339 | 420 | 520 | 441 | 357 | 416 |
Interest | 18 | 23 | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 17 |
Depreciation | 25 | 31 | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 137 |
Exceptional Income / Expenses | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 68 | 96 | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 262 |
Provision for Tax | 23 | 30 | 40 | 57 | 58 | 83 | 93 | 65 | 100 | 78 | 56 | 67 |
Profit After Tax | 45 | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 193 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 45 | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 193 |
Adjusted Earnings Per Share | 1.9 | 2.7 | 4.3 | 5 | 5 | 6.7 | 7.1 | 9.1 | 11.7 | 9.3 | 6.2 | 7.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 5% | 5% | 7% | 11% |
Operating Profit CAGR | -19% | -5% | 3% | 12% |
PAT CAGR | -34% | -12% | -1% | 13% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -3% | 7% | 19% | 36% |
ROE Average | 9% | 14% | 16% | 22% |
ROCE Average | 13% | 20% | 22% | 25% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 214 | 277 | 368 | 480 | 606 | 761 | 1105 | 1272 | 1572 | 1760 | 1855 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 150 | 114 | 145 | 113 | 71 | 39 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 33 | 35 | 34 | 43 | 33 | 35 | 43 | 155 | 154 | 161 | 169 |
Total Current Liabilities | 189 | 231 | 295 | 362 | 360 | 415 | 463 | 413 | 449 | 461 | 471 |
Total Liabilities | 587 | 657 | 841 | 997 | 1070 | 1250 | 1611 | 1841 | 2176 | 2383 | 2495 |
Fixed Assets | 327 | 366 | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1150 |
Other Non-Current Assets | 39 | 37 | 14 | 48 | 83 | 163 | 36 | 69 | 158 | 208 | 151 |
Total Current Assets | 221 | 254 | 355 | 419 | 447 | 562 | 727 | 791 | 1080 | 1187 | 1194 |
Total Assets | 587 | 657 | 841 | 997 | 1070 | 1250 | 1611 | 1841 | 2176 | 2383 | 2495 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 2 | 6 | 4 | 2 | 4 | 3 | 2 | 3 | 6 | 7 |
Cash Flow from Operating Activities | 54 | 125 | 107 | 159 | 180 | 154 | 123 | 319 | 513 | 56 | 400 |
Cash Flow from Investing Activities | -82 | -70 | -130 | -130 | -89 | -108 | -57 | -116 | -453 | 15 | -258 |
Cash Flow from Financing Activities | 29 | -51 | 21 | -31 | -89 | -46 | -68 | -203 | -56 | -70 | -138 |
Net Cash Inflow / Outflow | 1 | 4 | -1 | -2 | 1 | -0 | -2 | 1 | 4 | 1 | 3 |
Closing Cash & Cash Equivalent | 2 | 6 | 4 | 2 | 4 | 3 | 2 | 3 | 6 | 7 | 10 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.87 | 2.73 | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.12 | 11.74 | 9.35 | 6.21 |
CEPS(Rs) | 2.93 | 4.03 | 5.96 | 6.98 | 7.14 | 8.95 | 9.59 | 13.52 | 16.17 | 13.91 | 11.23 |
DPS(Rs) | 0 | 0.5 | 1 | 0.6 | 1 | 1.5 | 1.8 | 1.25 | 2.5 | 2.5 | 2.5 |
Book NAV/Share(Rs) | 8.93 | 11.52 | 15.32 | 20 | 25.11 | 31.44 | 44.25 | 50.93 | 63.01 | 70.62 | 74.51 |
Core EBITDA Margin(%) | 10.8 | 11.99 | 13.38 | 13.84 | 13.98 | 15.5 | 14.24 | 17.07 | 21.07 | 14.92 | 11.37 |
EBIT Margin(%) | 8.4 | 9.64 | 10.74 | 11.57 | 11.69 | 12.94 | 12.08 | 12.9 | 17.37 | 11.71 | 7.79 |
Pre Tax Margin(%) | 6.66 | 7.79 | 9.51 | 10.25 | 10.78 | 12.5 | 11.69 | 12.1 | 16.58 | 11.1 | 7.06 |
PAT Margin (%) | 4.41 | 5.35 | 6.87 | 6.94 | 7.26 | 8.27 | 7.65 | 9.39 | 12.36 | 8.31 | 5.19 |
Cash Profit Margin (%) | 6.92 | 7.9 | 9.53 | 9.66 | 10.38 | 11.05 | 10.38 | 13.93 | 17.02 | 12.37 | 9.4 |
ROA(%) | 8.44 | 10.55 | 13.76 | 13.08 | 11.6 | 13.88 | 12.26 | 13.11 | 14.52 | 10.21 | 6.33 |
ROE(%) | 23.16 | 26.74 | 31.98 | 28.37 | 22.15 | 23.69 | 18.93 | 19.16 | 20.61 | 14 | 8.55 |
ROCE(%) | 21.69 | 25.84 | 29.78 | 30.29 | 25.72 | 29.68 | 25.99 | 24.8 | 28.62 | 19.56 | 12.75 |
Receivable days | 10.58 | 15.51 | 18.29 | 20.09 | 25.62 | 27.78 | 31.53 | 29.88 | 27.35 | 28.18 | 31.98 |
Inventory Days | 51.69 | 48.15 | 50.21 | 56.28 | 63.64 | 56.58 | 55.45 | 62.85 | 67.29 | 71.42 | 75.91 |
Payable days | 38.67 | 39.13 | 49.54 | 63.85 | 62.37 | 62.13 | 59.01 | 62.44 | 73.96 | 66.68 | 64.91 |
PER(x) | 15.71 | 26.94 | 37.62 | 36.32 | 49.75 | 48.65 | 54.77 | 65.51 | 74.47 | 113.95 | 136.78 |
Price/Book(x) | 3.28 | 6.39 | 10.54 | 9.1 | 9.89 | 10.36 | 8.76 | 11.73 | 13.87 | 15.08 | 11.39 |
Dividend Yield(%) | 0 | 0.17 | 0.15 | 0.16 | 0.2 | 0.23 | 0.23 | 0.21 | 0.29 | 0.23 | 0.29 |
EV/Net Sales(x) | 0.92 | 1.62 | 2.78 | 2.69 | 3.77 | 4.11 | 4.24 | 6.16 | 9.2 | 10 | 7.57 |
EV/Core EBITDA(x) | 8.35 | 13.13 | 20.45 | 18.91 | 25.12 | 26.05 | 28.64 | 35.29 | 41.75 | 60.09 | 59.02 |
Net Sales Growth(%) | 16.79 | 20.05 | 22.15 | 15.6 | -4.71 | 19 | 18.08 | 5.17 | -2.13 | 12.47 | 4.88 |
EBIT Growth(%) | 18.26 | 38.41 | 36.33 | 24.42 | -3.7 | 30.64 | 9.81 | 12.31 | 31.76 | -20.02 | -29.33 |
PAT Growth(%) | 12.29 | 46.48 | 57 | 16.72 | -0.27 | 34.28 | 8.92 | 28.96 | 28.87 | -20.19 | -33.61 |
EPS Growth(%) | 12.29 | 46.49 | 57 | 16.73 | -0.36 | 34.06 | 5.67 | 28.86 | 28.76 | -20.36 | -33.61 |
Debt/Equity(x) | 1.05 | 0.72 | 0.65 | 0.49 | 0.3 | 0.2 | 0.1 | 0.02 | 0 | 0.01 | 0 |
Current Ratio(x) | 1.17 | 1.1 | 1.21 | 1.16 | 1.24 | 1.35 | 1.57 | 1.91 | 2.4 | 2.57 | 2.54 |
Quick Ratio(x) | 0.33 | 0.39 | 0.36 | 0.37 | 0.43 | 0.6 | 0.74 | 0.83 | 1.46 | 1.11 | 1.34 |
Interest Cover(x) | 4.82 | 5.22 | 8.72 | 8.76 | 12.84 | 29.36 | 30.84 | 16.08 | 21.93 | 19.06 | 10.7 |
Total Debt/Mcap(x) | 0.32 | 0.11 | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 | 0 | 0 | 0 | 0 |
# | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 70.92 | 70.92 | 70.78 | 70.78 | 70.78 | 70.78 | 71.02 | 71.25 | 71.27 | 71.27 |
FII | 3.49 | 3.56 | 3.81 | 3.22 | 3.15 | 3.11 | 2.99 | 2.81 | 2.88 | 3.24 |
DII | 7.34 | 7.17 | 7.08 | 6.94 | 7.06 | 7.44 | 7.64 | 7.96 | 8.34 | 8.53 |
Public | 18.25 | 18.35 | 18.33 | 19.06 | 19 | 18.67 | 18.35 | 17.98 | 17.52 | 16.96 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 17.62 | 17.62 | 17.62 | 17.62 | 17.62 | 17.62 | 17.68 | 17.74 | 17.74 | 17.74 |
FII | 0.87 | 0.88 | 0.95 | 0.8 | 0.78 | 0.77 | 0.74 | 0.7 | 0.72 | 0.81 |
DII | 1.82 | 1.78 | 1.76 | 1.73 | 1.76 | 1.85 | 1.9 | 1.98 | 2.08 | 2.12 |
Public | 4.53 | 4.56 | 4.56 | 4.74 | 4.73 | 4.65 | 4.57 | 4.48 | 4.36 | 4.22 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 24.84 | 24.84 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
See More Unlisted Share Articles
You May Also Know About